Search - tctmd.com

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Relationship Between Elevated BNP Levels in STEMI and Clinical Outcomes: The HORIZONS-AMI Trial

Presenter: Rudolf Jarai, Kurt Huber, Ke S. Xu, Bimmer Claessen, Georg Dangas, Roxana Mehran, Gregg Stone

January 03, 2012

Presentation TCT 2012

Relationship Between Angiographic Dynamic and Densitometric Assessment of Myocardial Reperfusion and Survival in Patients with Acute Myocardial Infarction Treated with Primary...

Presenter: Sorin J. Brener, Ecaterina Cristea, Roxana Mehran, Ovidiu Dressler, Alexandra J. Lansky, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Cerebrovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Undergoing a Primary PCI Management Strategy: Analysis from the HORIZONS-AMI Trial

Presenter: Eugenia Nikolsky, Bernard J. Gersh, Dangas D. George, Shing-Chiu Wong, Ke Xu, Martin Fahy, Roxana Mehran, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

Presenter: Patrick Tobbia, Bruce R. Brodie, Thomas Stuckey, Brent T. McLaurin, David Cox, Martin Fahy, Ke Xu, Roxana Mehran, Gregg W. Stone

January 03, 2012

News Conference News

Adenosine-Free Pressure Measurement Found Equivalent to FFR

L.A. McKeown

December 01, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Jason Kahn

September 06, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

Advertisement

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

HORIZONS-AMI: Las PCI mediante Acceso Radial Reducen las Hemorragias y los MACE en los STEMI

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Relationship Between Elevated BNP Levels in STEMI and Clinical Outcomes: The HORIZONS-AMI Trial

Relationship Between Angiographic Dynamic and Densitometric Assessment of Myocardial Reperfusion and Survival in Patients with Acute Myocardial Infarction Treated with Primary...

Cerebrovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Undergoing a Primary PCI Management Strategy: Analysis from the HORIZONS-AMI Trial

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

Adenosine-Free Pressure Measurement Found Equivalent to FFR

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

Ticagrelor Gains FDA Approval for Use in ACS

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Syntax Score Predicts 1-Year Risk in ACS Patients

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content